Alfredo Addeo MD(@Alfdoc2) 's Twitter Profileg
Alfredo Addeo MD

@Alfdoc2

Medical Oncologist, department of oncology at the University hospital of Geneva (HUG). All opinions expressed here are my own

ID:493367808

calendar_today15-02-2012 18:39:39

16,7K Tweets

2,4K Followers

121 Following

Jarushka Naidoo(@DrJNaidoo) 's Twitter Profile Photo

Lung cancer is not just invading the plenaries...but other tracks as well!

Looking forward to discussing 2 NSCLC abstracts in the
CNS orals:
- High-dose almonertinib in EGFR+ NSCLC with CNS mets
- Ph III METIS trial: TTF in NSCLC brain mets

ASCO Beaumont RCSI Cancer Centre

#ASCO24 Lung cancer is not just invading the plenaries...but other tracks as well! Looking forward to discussing 2 NSCLC abstracts in the CNS orals: - High-dose almonertinib in EGFR+ NSCLC with CNS mets - Ph III METIS trial: TTF in NSCLC brain mets @ASCO @CancerCentreIre #LCSM
account_circle
Giannis Mountzios(@g_mountzios) 's Twitter Profile Photo

The 7th National Hellenic oncology Congress ΕΟΠΕ just began , all of us and our special distinguished guest expert and amazing person Charu Aggarwal, MD, MPH, FASCO are looking forward to welcome all of you!!
Marita Lykka MD ESMO - Eur. Oncology IASLC ASCO OncoAlert

The 7th National Hellenic oncology Congress @HeSMO_X just began , all of us and our special distinguished guest expert and amazing person @CharuAggarwalMD are looking forward to welcome all of you!! #some #lcsm @marilykmd @myESMO @IASLC @ASCO @OncoAlert
account_circle
Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo

IASLC Members We Need Your Opinion! Dr. Narjust Florez, MD, FASCO encourages all of us to help shape the IASLC community by taking our 5-min survey in multiple languages to help us understand diverse needs & enhance initiatives. Let's build inclusivity together! gather.video/h7wo

account_circle
Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo

Results of phase III RESILIENT study of liposomal irinotecan vs topotecan in pts with relapsed (n=461) Journal of Clinical Oncology. Higher RR (44% vs 22%) but did not improve OS (7.9m vs 8.3m, HR 1.11) or PFS (4.0m vs 3.3m, HR 0.96). Fewer G3+ TEAEs (42% vs 83%).

ascopubs.org/doi/10.1200/JC…

account_circle
International Lung Cancer Summit(@LungSummit) 's Twitter Profile Photo

New study suggest that neoadjuvant platinum-based ICI-chemo. for those with early-stage is associated with improvements in 2-year EFS and pCR 🫁

See the full study in JAMA Network Open by Giuseppe Banna, Mona Hassan, Alfredo Addeo MD & colleagues ⬇️

jamanetwork.com/journals/jaman…

account_circle
Petra Jankowska(@petra_jankowska) 's Twitter Profile Photo

Totally 💯 MARS2 to be published soon - We should not be referring our mesothelioma patients for surgery - surgery causes harm!
BTOG

account_circle
Giuseppe Banna(@gbanna74) 's Twitter Profile Photo

Meta-analysis of neoadjuv chemoimmunotherapy in :
1. 3 cycles suffice based on pCR, with adjuvant immunotherapy not enhancing EFS.
2. Kudos to JAMA Network Open team, esp. Sara, for elevating paper quality & reviewers' feedback.
3. Special shoutout to the amazing team!

Meta-analysis of neoadjuv chemoimmunotherapy in #NSCLC: 1. 3 cycles suffice based on pCR, with adjuvant immunotherapy not enhancing EFS. 2. Kudos to @JAMANetworkOpen team, esp. Sara, for elevating paper quality & reviewers' feedback. 3. Special shoutout to the amazing team!
account_circle
Prof Ciro Rinaldi(@tamaciro) 's Twitter Profile Photo

So proud to speak at our Lincolnshire Research and Innocation HUB launch today 🙂 we will do great things together … watch this space World !

So proud to speak at our Lincolnshire Research and Innocation HUB launch today 🙂 we will do great things together … watch this space World !
account_circle